{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:01:23Z","timestamp":1791230483890,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1053\/j.seminhematol.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:43:07Z","timestamp":1680061387000},"page":"113-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Report of Consensus Panel 6 from the 11 th International Workshop on Waldenstr\u00f6m's Macroglobulinemia on Management of Waldenstr\u00f6m's Macroglobulinemia Related Amyloidosis"],"prefix":"10.1053","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-3254","authenticated-orcid":false,"given":"Giampaolo","family":"Merlini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna","family":"Sarosiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Benevolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Garcia-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe E.","family":"Gatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fernandez de Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"San-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Treon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique C.","family":"Minnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.002_bib0001","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41375-018-0286-7","article-title":"Primary systemic amyloidosis in patients with Waldenstrom macroglobulinemia","volume":"33","author":"Zanwar","year":"2019","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.002_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41408-021-00480-w","article-title":"Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies","volume":"11","author":"Rognvaldsson","year":"2021","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.002_bib0003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1515\/cclm-2021-0912","article-title":"Prospective urinary albumin\/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: results from a large cohort of patients","volume":"60","author":"Basset","year":"2022","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.03.002_bib0004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41408-020-00391-2","article-title":"Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients","volume":"10","author":"Visram","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2017.1.1","article-title":"AL amyloidosis: from molecular mechanisms to targeted therapies","volume":"2017","author":"Merlini","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"23","key":"10.1053\/j.seminhematol.2023.03.002_bib0006","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"136","author":"Palladini","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0007","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1038\/s41467-021-23880-9","article-title":"Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity","volume":"12","author":"Garofalo","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0008","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1038\/s41598-021-93019-9","article-title":"Exploring the sequence features determining amyloidosis in human antibody light chains","volume":"11","author":"Rawat","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.002_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ejhf.2769","article-title":"N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis","volume":"25","author":"Vergaro","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.002_bib0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MD.0b13e31816c43b6","article-title":"The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients","volume":"87","author":"Terrier","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.002_bib0012","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.bbmt.2018.12.003","article-title":"Autologous stem cell transplant for IgM-associated amyloid light-chain amyloidosis","volume":"25","author":"Sidiqi","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.03.002_bib0013","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2017-09-806463","article-title":"First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival","volume":"131","author":"Pika","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2023.03.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2021.107348","article-title":"Oerlemans MIF. Endomyocardial biopsy with co-localization of a lymphoplasmacytic lymphoma and AL amyloidosis","volume":"53","author":"Leguit","year":"2021","journal-title":"Cardiovasc Pathol"},{"issue":"18","key":"10.1053\/j.seminhematol.2023.03.002_bib0015","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.2020006844","article-title":"A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstrom macroglobulinemia: the ASPEN study","volume":"136","author":"Tam","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2021.2002841","article-title":"Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines","volume":"29","author":"Sanchorawala","year":"2022","journal-title":"Amyloid"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13506129.2022.2093635","article-title":"Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group","volume":"30","author":"Wechalekar","year":"2023","journal-title":"Amyloid"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.03.002_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.2019002762","article-title":"Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis","volume":"135","author":"Basset","year":"2020","journal-title":"Blood"},{"issue":"36","key":"10.1053\/j.seminhematol.2023.03.002_bib0019","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2020.1868810","article-title":"Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis","volume":"28","author":"Palladini","year":"2021","journal-title":"Amyloid"},{"issue":"19","key":"10.1053\/j.seminhematol.2023.03.002_bib0021","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.2020008737","article-title":"How I treat AL amyloidosis","volume":"139","author":"Palladini","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.002_bib0022","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.12102","article-title":"Response assessment in Waldenstrom macroglobulinaemia: update from the VIth international workshop","volume":"160","author":"Owen","year":"2013","journal-title":"Br J Haematol"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2023.03.002_bib0023","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2022-160018","article-title":"Use of matrix-assisted laser desorption\/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) free light chain assessment for the diagnosis and monitoring of systemic immunoglobulin light chain (AL) amyloidosis","volume":"140","author":"Bomsztyk","year":"2022","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2023.03.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.3261.3261","article-title":"Persistence of minimal residual disease by multiparameter flow cytometry can hinder recovery of organ damage in patients with AL amyloidosis otherwise in complete response","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13506129.2020.1802713","article-title":"Next generation flow cytometry for MRD detection in patients with AL amyloidosis","volume":"28","author":"Kastritis","year":"2021","journal-title":"Amyloid"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.03.002_bib0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.beha.2016.08.013","article-title":"Monoclonal IgM-related AL amyloidosis","volume":"29","author":"Milani","year":"2016","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.seminhematol.2023.03.002_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.935936","article-title":"Multidisciplinary amyloidosis care in the era of personalized medicine","volume":"13","author":"Bumma","year":"2022","journal-title":"Front Neurol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.03.002_bib0028","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41375-019-0667-6","article-title":"IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features","volume":"34","author":"Sidana","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.03.002_bib0029","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.clml.2022.02.005","article-title":"SOHO state of the art updates and next questions: targeted therapies and emerging novel treatment approaches for Waldenstrom macroglobulinemia","volume":"22","author":"Sermer","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.03.002_bib0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/hematology.2020000121","article-title":"Management of Waldenstrom macroglobulinemia in 2020","volume":"2020","author":"Castillo","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.03.002_bib0031","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1053\/j.seminhematol.2023.03.002_bib0032","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:21Z","timestamp":1758522501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0037196323000227"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.03.002","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Report of Consensus Panel 6 from the 11 th International Workshop on Waldenstr\u00f6m's Macroglobulinemia on Management of Waldenstr\u00f6m's Macroglobulinemia Related Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}